Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study
D Schrijvers, C Van Herpen, J Kerger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2012
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
E Seront, S Rottey, B Sautois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2005
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study
J-P Machiels, L Duck, B Honhon, et al.
Gynecologic Oncology
|
May 11, 2023
Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer
I Vergote, E Van Nieuwenhuysen, A Casado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2001
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer
M J Piccart, A Di Leo, M Beauduin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2007
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
J-P Machiels, C Sempoux, P Scalliet, et al.
International Journal of Cancer
|
February 6, 1999
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
M Marchand, N van Baren, P Weynants, et al.
British Journal of Cancer
|
July 7, 2012
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
A Roy, D Cunningham, R Hawkins, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study
D Schrijvers, C Van Herpen, J Kerger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2012
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
E Seront, S Rottey, B Sautois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2005
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study
J-P Machiels, L Duck, B Honhon, et al.
Gynecologic Oncology
|
May 11, 2023
Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer
I Vergote, E Van Nieuwenhuysen, A Casado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2001
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer
M J Piccart, A Di Leo, M Beauduin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2007
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
J-P Machiels, C Sempoux, P Scalliet, et al.
International Journal of Cancer
|
February 6, 1999
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
M Marchand, N van Baren, P Weynants, et al.
British Journal of Cancer
|
July 7, 2012
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
A Roy, D Cunningham, R Hawkins, et al.
Page
of 3